Immune responses: Costimulatory receptors have their say

Current Biology

Volumn 8, Issue 16, 1998, Pages

  Weintraub, Bennett C ^a   Goodnow, Christopher C ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 13144251120     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0960-9822(07)00365-x     Document Type: Article

References (24)

1. Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF: CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 1997, 186:1923-1931.
2. Harlan DM, Hengartner H, Huang ML, Kang YH, Abe R, Moreadith RW, Pircher H, Gray GS, Ohashi PS, Freeman GJ, et al.: Mice expressing both B7-1 and viral glycoprotein on pancreatic β cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc Natl Acad Sci USA 1994, 91:3137-3141.
3. Guerder S, Picarella DE, Linsley PS, Flavell RA: Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor a leads to autoimmunity in transgenic mice. Proc Natl Acad Sci USA 1994, 91:5138-5142.
4. Schwartz RH: T cell clonal anergy. Curr Opin Immunol 1997, 9:351-357.
5. Goodnow CC, Cyster JG, Hartley SB, Bell SE, Cooke MP, Healy JI, Akkaraju S, Rathmell JC, Pogue SL, Shokat KP: Self-tolerance checkpoints in B lymphocyte development. Adv Immunol 1995, 59:279-368.
6. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996, 14:233-258.
7. June CH, Ledbetter JA, Linsley PS, Thompson CB: Role of the CD28 receptor in T-cell activation. Immunol Today 1990, 11:211-216.
8. Allison JP: CD28-B7 interactions in T-cell activation. Curr Opin Immunol 1994, 6:414-419.
9. Fearon DT, Carter RH: The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol 1995, 13:127-149.
10. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT: C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996, 271:348-350.
11. Carroll MC, Fischer MB: Complement and the immune response. Curr Opin Immunol 1997, 9:64-69.
12. Healy JI, Dolmetsch RE, Timmerman LA, Cyster JG, Thomas ML, Crabtree GR, Lewis RS, Goodnow CC: Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 1997, 6:419-428.
13. + T cells. Science 1996, 271:1272-1276.
14. 2-terminal kinase and mitogen-activated protein kinase signaling pathways. J Exp Med 1996, 183:2017-2023.
15. Sundstedt A, Sigvardsson M, Leanderson T, Hedlund G, Kalland T, Dohlsten M: In vivo anergized CD4+ T cells express perturbed AP-1 and NF-κB transcription factors. Proc Natl Acad Sci USA 1996, 93:979-984.
16. Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben-Neriah Y: JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994, 77:727-736.
17. Alkalay I, Yaron A, Hatzbuai A, Jung S, Avraham A, Gerlitz O, Pashut-Lavon I, Ben-Neriah Y: In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB. Mol Cell Biol 1995, 15:1294-1301.
18. Tooze RM, Doody GM, Fearon DT: Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity 1997, 7:59-67.
19. Li X, Sandoval D, Freeberg L, Carter RH: Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig. J Immunol 1997, 158:5649-5657.
20. Weng WK, Shah N, O'Brien D, Van Ness B, Lebien TW: Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cells. J Immunol 1997, 159:5502-5508.
21. 2+ mobilization. J Exp Med 1997, 186:1897-1910.
22. Hutchcroft JE, Bierer BE: Signaling through CD28/CTLA-4 family receptors: puzzling participation of phosphatidylinositol-3 kinase. J Immunol 1996, 156:4071-4074.
23. Weng WK, Jarvis L, Lebien TW: Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J Biol Chem 1994, 269:32514-32521.
24. Collingridge GL: Coincidence detection during the induction of NMDA receptor-dependent LTP. In Coincidence Detection in the Nervous System. Edited by Konnerth A, Tsien RY, Mikoshiba K, Altman J. Strasbourg: Human Frontiers Science Program; 1996:63-73.